Trial no.:
|
PACTR202403873496250 |
Date of Approval:
|
01/03/2024 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Effects of oral clonidine pre-medication on intra-operative blood loss during caesarean section under sub-arachnoid block |
Official scientific title |
Effects of Oral Clonidine Pre-medication on Intra-Operative Blood Loss during Caesarean Section under Sub-Arachnoid Block in Federal Teaching Hospital Abakaliki |
Brief summary describing the background
and objectives of the trial
|
Caesarean section is known to be associated with several complications, of which excessive intra-operative bleeding stands out. Though several methods have been used to limit intra-operative haemorrhage during caesarean section, these are not without their limitations. Clonidine, an oral anti-hypertensive drug, has been suggested as being able to significantly reduce intra-operative blood loss. The objective of the study is to assess the effects of oral clonidine premedication on the intra-operative blood loss, maternal haemodynamic stability and neonatal outcome during caesarean sections under subarachnoid block (SAB). |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Pregnancy and Childbirth |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Prevention |
Anticipated trial start date |
26/03/2018 |
Actual trial start date |
02/04/2018 |
Anticipated date of last follow up |
09/11/2018 |
Actual Last follow-up date |
05/11/2018 |
Anticipated target sample size (number of participants) |
160 |
Actual target sample size (number of participants) |
158 |
Recruitment status |
Completed |
Publication URL |
|
|